47.01 USD
-0.69 (-1.45%)
47.4 USD
+0.39 (+0.83%)
We assign a fundamental rating of 6 out of 10 to COLL. COLL was compared to 191 industry peers in the Pharmaceuticals industry. COLL scores excellent on profitability, but there are some minor concerns on its financial health. COLL scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make COLL a good candidate for value investing.
1. Profitability
1.1 Basic Checks
- COLL had positive earnings in the past year.
- COLL had a positive operating cash flow in the past year.
- Of the past 5 years COLL 4 years were profitable.
- COLL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 3.64%, COLL belongs to the best of the industry, outperforming 83.77% of the companies in the same industry.
- The Return On Equity of COLL (21.27%) is better than 91.10% of its industry peers.
- With an excellent Return On Invested Capital value of 9.10%, COLL belongs to the best of the industry, outperforming 87.96% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for COLL is in line with the industry average of 12.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.64% | ||
| ROE | 21.27% | ||
| ROIC | 9.1% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
1.3 Margins
- COLL has a better Profit Margin (7.72%) than 82.72% of its industry peers.
- In the last couple of years the Profit Margin of COLL has declined.
- Looking at the Operating Margin, with a value of 20.74%, COLL belongs to the top of the industry, outperforming 88.48% of the companies in the same industry.
- COLL's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 57.22%, COLL is in the better half of the industry, outperforming 68.59% of the companies in the same industry.
- COLL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.74% | ||
| PM (TTM) | 7.72% | ||
| GM | 57.22% |
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so COLL is still creating some value.
- COLL has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, COLL has less shares outstanding
- Compared to 1 year ago, COLL has an improved debt to assets ratio.
2.2 Solvency
- COLL has an Altman-Z score of 1.49. This is a bad value and indicates that COLL is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 1.49, COLL is in line with its industry, outperforming 54.97% of the companies in the same industry.
- The Debt to FCF ratio of COLL is 2.79, which is a good value as it means it would take COLL, 2.79 years of fcf income to pay off all of its debts.
- COLL has a better Debt to FCF ratio (2.79) than 91.10% of its industry peers.
- A Debt/Equity ratio of 2.71 is on the high side and indicates that COLL has dependencies on debt financing.
- COLL has a Debt to Equity ratio of 2.71. This is amonst the worse of the industry: COLL underperforms 80.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 2.79 | ||
| Altman-Z | 1.49 |
ROIC/WACC0.98
WACC9.26%
2.3 Liquidity
- A Current Ratio of 1.36 indicates that COLL should not have too much problems paying its short term obligations.
- COLL has a worse Current ratio (1.36) than 74.35% of its industry peers.
- A Quick Ratio of 1.27 indicates that COLL should not have too much problems paying its short term obligations.
- With a Quick ratio value of 1.27, COLL is not doing good in the industry: 70.68% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.27 |
3. Growth
3.1 Past
- COLL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.73%, which is quite impressive.
- Measured over the past years, COLL shows a very strong growth in Earnings Per Share. The EPS has been growing by 154.78% on average per year.
- The Revenue has grown by 26.34% in the past year. This is a very strong growth!
- COLL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.31% yearly.
EPS 1Y (TTM)30.73%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%39.75%
Revenue 1Y (TTM)26.34%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%31.42%
3.2 Future
- Based on estimates for the next years, COLL will show a decrease in Earnings Per Share. The EPS will decrease by -1.58% on average per year.
- Based on estimates for the next years, COLL will show a small growth in Revenue. The Revenue will grow by 3.62% on average per year.
EPS Next Y18.1%
EPS Next 2Y12.32%
EPS Next 3Y-0.6%
EPS Next 5Y-1.58%
Revenue Next Year24.13%
Revenue Next 2Y13.42%
Revenue Next 3Y4.47%
Revenue Next 5Y3.62%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 6.54, the valuation of COLL can be described as very cheap.
- 93.72% of the companies in the same industry are more expensive than COLL, based on the Price/Earnings ratio.
- COLL is valuated cheaply when we compare the Price/Earnings ratio to 27.32, which is the current average of the S&P500 Index.
- COLL is valuated cheaply with a Price/Forward Earnings ratio of 5.78.
- Based on the Price/Forward Earnings ratio, COLL is valued cheaply inside the industry as 93.72% of the companies are valued more expensively.
- COLL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.54 | ||
| Fwd PE | 5.78 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, COLL is valued cheaply inside the industry as 98.43% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, COLL is valued cheaper than 96.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.14 | ||
| EV/EBITDA | 4.94 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- COLL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y12.32%
EPS Next 3Y-0.6%
5. Dividend
5.1 Amount
- No dividends for COLL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
47.01
-0.69 (-1.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners120.33%
Inst Owner Change1.05%
Ins Owners1.42%
Ins Owner Change-0.82%
Market Cap1.49B
Revenue(TTM)757.07M
Net Income(TTM)58.44M
Analysts81.67
Price Target54.23 (15.36%)
Short Float %17.42%
Short Ratio9.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.9%
Min EPS beat(2)1.88%
Max EPS beat(2)7.92%
EPS beat(4)4
Avg EPS beat(4)6.15%
Min EPS beat(4)1.88%
Max EPS beat(4)12.85%
EPS beat(8)7
Avg EPS beat(8)12.99%
EPS beat(12)9
Avg EPS beat(12)-15.06%
EPS beat(16)10
Avg EPS beat(16)-21.97%
Revenue beat(2)2
Avg Revenue beat(2)5.22%
Min Revenue beat(2)1.9%
Max Revenue beat(2)8.53%
Revenue beat(4)3
Avg Revenue beat(4)2.75%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)8.53%
Revenue beat(8)4
Avg Revenue beat(8)0.8%
Revenue beat(12)6
Avg Revenue beat(12)0.28%
Revenue beat(16)8
Avg Revenue beat(16)-3.75%
PT rev (1m)13.6%
PT rev (3m)19.21%
EPS NQ rev (1m)-3.66%
EPS NQ rev (3m)3.93%
EPS NY rev (1m)-0.9%
EPS NY rev (3m)-9.58%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)3.24%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)3.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.54 | ||
| Fwd PE | 5.78 | ||
| P/S | 1.96 | ||
| P/FCF | 5.14 | ||
| P/OCF | 5.11 | ||
| P/B | 5.41 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.94 |
EPS(TTM)7.19
EY15.29%
EPS(NY)8.14
Fwd EY17.31%
FCF(TTM)9.15
FCFY19.47%
OCF(TTM)9.2
OCFY19.58%
SpS23.95
BVpS8.69
TBVpS-18.86
PEG (NY)0.36
PEG (5Y)N/A
Graham Number37.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.64% | ||
| ROE | 21.27% | ||
| ROCE | 13.6% | ||
| ROIC | 9.1% | ||
| ROICexc | 12.09% | ||
| ROICexgc | N/A | ||
| OM | 20.74% | ||
| PM (TTM) | 7.72% | ||
| GM | 57.22% | ||
| FCFM | 38.21% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score7
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 2.79 | ||
| Debt/EBITDA | 1.94 | ||
| Cap/Depr | 0.72% | ||
| Cap/Sales | 0.21% | ||
| Interest Coverage | 2.17 | ||
| Cash Conversion | 75.92% | ||
| Profit Quality | 495.01% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 1.49 |
F-Score7
WACC9.26%
ROIC/WACC0.98
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.73%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%39.75%
EPS Next Y18.1%
EPS Next 2Y12.32%
EPS Next 3Y-0.6%
EPS Next 5Y-1.58%
Revenue 1Y (TTM)26.34%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%31.42%
Revenue Next Year24.13%
Revenue Next 2Y13.42%
Revenue Next 3Y4.47%
Revenue Next 5Y3.62%
EBIT growth 1Y-18.86%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year154.57%
EBIT Next 3Y23.61%
EBIT Next 5Y18.85%
FCF growth 1Y8.55%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y8.67%
OCF growth 3Y25.54%
OCF growth 5Y49.12%
COLLEGIUM PHARMACEUTICAL INC / COLL FAQ
What is the ChartMill fundamental rating of COLLEGIUM PHARMACEUTICAL INC (COLL) stock?
ChartMill assigns a fundamental rating of 6 / 10 to COLL.
What is the valuation status for COLL stock?
ChartMill assigns a valuation rating of 9 / 10 to COLLEGIUM PHARMACEUTICAL INC (COLL). This can be considered as Undervalued.
What is the profitability of COLL stock?
COLLEGIUM PHARMACEUTICAL INC (COLL) has a profitability rating of 8 / 10.
Can you provide the financial health for COLL stock?
The financial health rating of COLLEGIUM PHARMACEUTICAL INC (COLL) is 5 / 10.